申请人:VenatoRx Pharmaceuticals, Inc.
公开号:US20140194386A1
公开(公告)日:2014-07-10
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
本文描述了一些调节β-内酰胺酶活性的化合物和组合物。在某些实施例中,本文所描述的化合物可以抑制β-内酰胺酶。在某些实施例中,本文所描述的化合物对治疗细菌感染是有用的。